Our Values
Message
Corporate Philosophy
Sawai at a Glance
Transparency
Products
Quality Policy & Feature of Each Function
ESG Data（Related Content）New Window
Sustainability
Sustainability Initiatives
Our Approach
Integrated Report（Related Content）New Window
Our Humanistic Business
Corporate Profile
Corporate History
InvestorsNew Window
Dec. 05. 2024
Sawai Announces Listing of Five Generic Drugs with 10 Strengths
Aug. 16. 2024
Sawai Receives Approvals for Six Generic Drugs with 11 Strengths
Jun. 13. 2024
Sawai Announces Listing of Two Generic Drugs with Three Strengths
Feb. 15. 2024
Sawai Receives Approvals for Three Generic Drugs with Four Strengths
